Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:3.5.4.4 (adenosine deaminase)
 5,136 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

In the motor neurons of amyotrophic lateral sclerosis (ALS) patients, an RNA editing enzyme called adenosine deaminase acting on RNA 2 (ADAR2) is down-regulated and consequently GluA2 mRNAs unedited at the Q/R site is expressed in contrast to normal motor neurons that express only GluA2 edited at this site. Motor neurons of the mice lacking ADAR2 undergo Ca(2+)-permeable AMPA receptor-mediated slow death. We investigated the spinal cords of conditional ADAR2-knockout mice modeling ALS for the involvement of autophagy. In the motor neurons of the early- and late-symptomatic-stage mice, LC3-immunopositivity or immunoreactivity for both LC3- and p62 was observed, whereas the presymptomatic-stage mice showed no LC3- or p62-immunoreactivity. Western blot analyses showed increased expression of autophagy associated proteins in the anterior horn of the early symptomatic-stage mice. Electron-microscopically, autophagy was observed in the motor neurons most frequently in the early-symptomatic-stage mice which showed the severest motor neuron degeneration. Increased autophagy flux was not recognized in the wild-type mice or AR2res (ADAR2(flox/flox)/VAChT-Cre. Fast/GluR-B(R)(/)(R)) mice having motor neurons genetically engineered to express normally edited GluA2 in the absence of ADAR2, which show normal Ca(2+)-permeability of the AMPA receptors in motor neurons. Significantly increased autophagy flux in the degenerating motor neurons of ADAR2-knockout mice likely resulted from Ca(2+) overload.
...
PMID:Autophagy in spinal motor neurons of conditional ADAR2-knockout mice: An implication for a role of calcium in increased autophagy flux in ALS. 2598 Sep 94

RNA editing, particularly A-to-I RNA editing, has been shown to play an essential role in mammalian embryonic development and tissue homeostasis, and is implicated in the pathogenesis of many diseases including skin pigmentation disorder, autoimmune and inflammatory tissue injury, neuron degeneration, and various malignancies. A-to-I RNA editing is carried out by a small group of enzymes, the adenosine deaminase acting on RNAs (ADARs). Only three members of this protein family, ADAR1-3, exist in mammalian cells. ADAR3 is a catalytically null enzyme and the most significant function of ADAR2 was found to be in editing on the neuron receptor GluR-B mRNA. ADAR1, however, has been shown to play more significant roles in biological and pathological conditions. Although there remains much that is not known about how ADAR1 regulates cellular function, recent findings point to regulation of the innate immune response as an important function of ADAR1. Without appropriate RNA editing by ADAR1, endogenous RNA transcripts stimulate cytosolic RNA sensing receptors and therefore activate the IFN-inducing signaling pathways. Overactivation of innate immune pathways can lead to tissue injury and dysfunction. However, obvious gaps in our knowledge persist as to how ADAR1 regulates innate immune responses through RNA editing. Here, we review critical findings from ADAR1 mechanistic studies focusing on its regulatory function in innate immune responses and identify some of the important unanswered questions in the field.
 ...
PMID:RNA Editing, ADAR1, and the Innate Immune Response. 2810 99


<< Previous 1 2